<--- Back to Details
First PageDocument Content
Health / Food and Drug Administration / Pharmaceuticals policy / Medicine / Food law / Dietary supplements / United States Public Health Service / Paul Offit / Good manufacturing practice / Federal Food /  Drug /  and Cosmetic Act / Adverse effect / Form FDA 483
Date: 2014-01-13 17:41:22
Health
Food and Drug Administration
Pharmaceuticals policy
Medicine
Food law
Dietary supplements
United States Public Health Service
Paul Offit
Good manufacturing practice
Federal Food
Drug
and Cosmetic Act
Adverse effect
Form FDA 483

Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docx

Add to Reading List

Source URL: www.mineralresourcesint.com

Download Document from Source Website

File Size: 85,25 KB

Share Document on Facebook

Similar Documents

Perelman School of Medicine at The University of Pennsylvania Paul A. Offit, MD Office Address:

Perelman School of Medicine at The University of Pennsylvania Paul A. Offit, MD Office Address:

DocID: 1vr9a - View Document

Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docx

Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docx

DocID: 1r1ru - View Document

Microsoft Word - Letter to Paul Offit re MMR booster _10_

Microsoft Word - Letter to Paul Offit re MMR booster _10_

DocID: 1pk3x - View Document

Elizabeth Hart Adelaide, South Australia  For the attention of: Dr David Tovey Editor in Chief, The Cochrane Library, and Deputy Chief Executive Officer

Elizabeth Hart Adelaide, South Australia For the attention of: Dr David Tovey Editor in Chief, The Cochrane Library, and Deputy Chief Executive Officer

DocID: 1oCjt - View Document

PDF Document

DocID: 1gBlK - View Document